scPharmaceuticals Inc. - Common Stock (SCPH)

Historical Holders from Q4 2017 to Q1 2025

Symbol
SCPH on Nasdaq
CUSIP
810648105
Type / Class
Equity / Common Stock
Shares outstanding
50M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
39.8M
Holdings value
$141M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
85
Number of buys
46
Number of sells
-40
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of scPharmaceuticals Inc. - Common Stock (SCPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIRSCHMAN ORIN 8.4% $12.6M 4.2M Orin Hirschman Dec 31, 2024
KING LUTHER CAPITAL MANAGEMENT CORP 6% $8.91M 2.98M J. Luther King, Jr. Dec 31, 2024

Institutional Holders of scPharmaceuticals Inc. - Common Stock (SCPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 115K $303K +$38.4K $2.63 4
2024 Q4 39.8M $141M +$5.28M $3.54 85
2024 Q3 37.3M $170M +$42.7M $4.56 93
2024 Q2 27.8M $121M +$4.5M $4.35 77
2024 Q1 26.7M $134M -$7.69M $5.02 76
2023 Q4 27.9M $175M -$15.6M $6.27 78
2023 Q3 29.9M $213M +$9.11M $7.12 73
2023 Q2 28.5M $291M +$40.8M $10.19 81
2023 Q1 24.6M $223M +$13.3M $9.07 63
2022 Q4 21.4M $154M +$53.7M $7.17 59
2022 Q3 14M $91.3M -$10.1M $6.52 38
2022 Q2 15.7M $75.9M -$3.64M $4.82 37
2022 Q1 15.9M $90.1M -$1.16M $5.68 34
2021 Q4 15.9M $80M -$1.6M $5.02 29
2021 Q3 16.2M $108M +$1.49M $6.65 30
2021 Q2 16M $97.9M -$7.16M $6.11 35
2021 Q1 17.2M $114M +$1.44M $6.65 45
2020 Q4 16.3M $86.3M -$6.51M $5.29 45
2020 Q3 17.1M $127M -$2.88M $7.45 48
2020 Q2 17.5M $129M +$36.7M $7.36 49
2020 Q1 12.5M $92.4M +$10.2M $7.40 32
2019 Q4 11.1M $62.7M +$1.61M $5.66 26
2019 Q3 7.58M $44.5M +$1.47M $5.89 24
2019 Q2 7.37M $23.5M -$277K $3.19 27
2019 Q1 7.48M $22.5M -$1.27M $3.00 32
2018 Q4 7.85M $29.5M -$769K $3.76 31
2018 Q3 8.05M $47.2M -$121K $5.87 30
2018 Q2 8.09M $45.8M -$6.15M $5.66 36
2018 Q1 8.32M $103M +$6.69M $12.40 37
2017 Q4 7.8M $94.1M +$94.1M $12.09 23